Could there be now something better compared to Byetta? The marketing folks at Novo Nordisk certainly want us to believe so. In January 2010 regulators gave the approval of theirs to promote the brand new drug for type two diabetes named Victoza in the world’s biggest market for diabetes drugs, the USA.
Victoza is a brand new drug in the group of medications called GLP 1 analogues. Glucagon-like peptide 1, or maybe GLP 1 for short, is a hormone secreted by the lining of the intestines of yours when there is food in the gut of yours. GLP-1 has a number of features which help lower blood sugars. Victoza:
So what’s to never love about any drug that mimics GLP-1?
The problem is sometimes the total impact of the medication is to lower blood sugars, and sometimes medicines in this category, that also contains Byetta, raise blood sugars. And both glucotrust side effects may be drastic.
The typical benefit of taking either Victoza or Byetta is a lowering of the HbA1c level of yours of about 1 %. That’s extremely useful, but you get very much benefit from the far less costly metformin or the absolutely cost-free changes you are able to make in the blood glucose levels of yours with an intelligent plant-based diet.